Get all your news in one place.
100’s of premium titles.
One app.
Start reading

Alleged 'Ketamine Queen' Charged In Matthew Perry's Death Case

Matthew Perry appears at the premiere of "Ride" in Los Angeles on April 28, 2015. (Photo by Rich Fury/Invision/AP, File)

Jasveen Sangha, known as the 'Ketamine Queen,' has been charged in connection with the death of actor Matthew Perry. Sangha, an alleged underground drug dealer, traveled overseas shortly after Perry's passing, as revealed through her Instagram posts.

Following Perry's death from the 'acute effects of ketamine,' Sangha posted about her travels to Japan and Mexico, showcasing luxurious experiences and carefree moments with friends. Despite the serious charges against her, Sangha appeared to maintain an active social life and exuded a carefree attitude.

According to US attorney Martin Estrada, Sangha allegedly provided Perry with a significant amount of ketamine in exchange for cash. The charges against Sangha include conspiracy to distribute ketamine, maintaining drug-involved premises, possession with intent to distribute methamphetamine, and distribution of ketamine.

Sangha traveled overseas after Perry's passing, showcasing a carefree lifestyle.
Jasveen Sangha charged in connection with Matthew Perry's death.
US attorney Martin Estrada accuses Sangha of providing ketamine to Perry.

Sangha pleaded not guilty in a Los Angeles federal court and faces a minimum sentence of 10 years in prison, with a maximum of life imprisonment. Her trial is scheduled for October 8.

Dr. Salvador Plasencia and Kenneth 'Kenny' Iwamasa are also implicated in Perry's case for their alleged roles in providing drugs to the actor. Perry's family has expressed their desire for justice to be served in this matter.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.